States seek to expand lawsuit against generic drugmakers

October 31, 2017
States seek to expand lawsuit against generic drugmakers
In this Tuesday, Feb. 5, 2013, file photo, Connecticut Attorney General George Jepsen speaks at the Justice Department in Washington. On Tuesday, Oct. 31, 2017, Jepsen and 45 of his colleagues sought to expand a federal antitrust lawsuit against generic drugmakers to include more manufacturers and medications, as well as senior executives at two companies. (AP Photo/Jacquelyn Martin, File)

Connecticut's attorney general and 45 of his colleagues are seeking to expand a federal antitrust lawsuit against generic drugmakers to include more manufacturers and medications, as well as senior executives at two companies.

Led by Connecticut, the states sought a federal court's permission Tuesday to widen their complaint, which alleges a number of illegal agreements among 18 manufacturers to fix prices and divvy up the market for specific generic drugs including treatments for high blood pressure, arthritis and asthma.

Mylan N.V., one of the drugmakers named in the suit, said it has investigated the allegations thoroughly and "found no evidence of price fixing." Mylan also said it stands by Rajiv Malik, its president since January 2012 who was named in the expanded complaint.

Based outside of Pittsburgh, Mylan makes a range of generic and branded drugs, including the EpiPen emergency allergy injector. Shares of the company slid 6.6 percent to close at $35.71.

The original lawsuit filed last year claimed six drugmakers artificially inflated and manipulated prices for two drugs, an antibiotic and a diabetes drug. At the time, Connecticut Attorney General George Jepsen said "it was just the tip of the iceberg."

Jepsen said Tuesday the alleged collusion is "so pervasive that it essentially eliminated competition from the market" for 15 generic drugs.

Explore further: States seek to expand lawsuit against generic drug-makers

Related Stories

States seek to expand lawsuit against generic drug-makers

October 31, 2017
Connecticut's attorney general and 45 of his colleagues are seeking to expand a federal antitrust lawsuit against generic drug-makers to include more manufacturers and medications, as well as senior executives at two companies.

Generic drugmakers want antitrust lawsuit dismissed

May 3, 2017
Six generic drugmakers are asking a federal judge in Connecticut to dismiss a 40-state lawsuit accusing them of artificially inflating and manipulating prices to reduce competition for antibiotic and oral diabetes medication.

Connecticut leads 20-state lawsuit over drug pricing

December 15, 2016
Six generic drug-makers artificially inflated and manipulated prices to reduce competition for an antibiotic and oral diabetes medication, 20 state attorneys general, led by Connecticut, said in a federal lawsuit filed Thursday.

EpiPen maker finalizes settlement for government overcharges

August 17, 2017
EpiPen maker Mylan has finalized a $465 million government agreement settling allegations it overbilled Medicaid for its emergency allergy injectors for a decade—charges brought after rival Sanofi filed a whistleblower ...

Mylan, like other generic drugmakers, feels the pricing pain

August 9, 2017
Mylan's second-quarter profit and revenue surged, but not as much as Wall Street had expected and the company is taking a more conservative view going forward because of "ongoing challenges and the uncertain U.S. regulatory ...

FDA takes steps to boost generic competition, limit prices

June 27, 2017
The Food and Drug Administration is taking steps to boost the number of generic prescription drugs in an effort to make medicines more affordable and to prevent price gouging.

Recommended for you

New study finds concurrent use of prescription drugs and dietary supplements could pose health risks

September 25, 2018
A new University of Hertfordshire study found that using certain over-the-counter herbal medicines and dietary supplements alongside prescription drugs could pose serious health risks, especially amongst older adults.

Drug overdose epidemic has been growing exponentially for decades

September 20, 2018
Death rates from drug overdoses in the U.S. have been on an exponential growth curve that began at least 15 years before the mid-1990s surge in opioid prescribing, suggesting that overdose death rates may continue along this ...

Anti-cancer drugs may hold key to overcoming antimalarial drug resistance

September 20, 2018
Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.

Probiotic use may reduce antibiotic prescriptions, researchers say

September 14, 2018
Use of probiotics is linked to reduced need for antibiotic treatment in infants and children, according to a review of studies that probed the benefits of probiotics, say researchers in the U.S., England and the Netherlands.

Recalled blood pressure drugs not linked to increased short term cancer risk

September 12, 2018
Products containing the withdrawn blood pressure drug valsartan are not associated with a markedly increased short term risk of cancer, finds an expedited analysis published by The BMJ today.

Sugar pills relieve pain for chronic pain patients

September 12, 2018
Someday doctors may prescribe sugar pills for certain chronic pain patients based on their brain anatomy and psychology. And the pills will reduce their pain as effectively as any powerful drug on the market, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.